首页> 外国专利> Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells

Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells

机译:特异性结合VCAM-1并抑制白细胞与内皮细胞之间粘附和转运的人重组单克隆抗体

摘要

The present invention relates to a human recombinant monoclonal antibody that specifically binds to human Vascular Cell Adhesion Molecule-1 (VCAM-1) to inhibit adhesion between leukocytes and activated endothelial cells and transmigration of leukocytes through the activated endothelial cells, and a prophylactic and therapeutic composition for inflammatory disease or cancer comprising the same. The human recombinant monoclonal antibody according to the present invention shows a strong affinity to VCAM-1 expressed on human endothelial cell, and effectively inhibits VCAM-1-mediated adhesion between leukocytes and activated endothelial cells and transmigration of leukocytes through the activated endothelial cells, thereby being used for the prevention and treatment of inflammatory disease such as asthma and arthritis, transplant rejection, cardiovascular disease, and cancer.
机译:本发明涉及与人血管细胞粘附分子-1(VCAM-1)特异性结合以抑制白细胞和活化的内皮细胞之间的粘附以及白细胞通过活化的内皮细胞的迁移的人重组单克隆抗体,以及预防和治疗用于炎性疾病或癌症的组合物,包括该组合物。根据本发明的人重组单克隆抗体对在人内皮细胞上表达的VCAM-1表现出强亲和力,并有效抑制VCAM-1介导的白细胞和活化的内皮细胞之间的粘附以及白细胞通过活化的内皮细胞的迁移,从而用于预防和治疗炎症性疾病,例如哮喘和关节炎,移植排斥,心血管疾病和癌症。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号